Cornerstone Capital Management Holdings’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,850	Closed	-$42K	–	1624
2015 Q3	$42K	Hold	2,850	–	–	﹤0.01%	1416
2015 Q2	$56K	Buy	+2,850	New	+$55K	﹤0.01%	1352
2015 Q1	–	Sell	-9,380	Closed	-$221K	–	1485
2014 Q4	$221K	Buy	+9,380	New	+$217K	﹤0.01%	1081
2014 Q3	–	Sell	-29,300	Closed	-$822K	–	1441
2014 Q2	$822K	Buy	+29,300	New	+$880K	0.01%	905

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cornerstone Capital Management Holdings's CTIC Position: Q4 2015 in Review

Cornerstone Capital Management Holdings sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2015, closing a stake of 2,850 shares — an estimated $42K sold.

Cornerstone Capital Management Holdings first reported a position in CTIC in Q2 2014 and held it in 4 quarters. The position peaked at $822K in Q2 2014. 94 funds tracked by Wall St. Rank hold CTIC as of Q4 2015.

Cornerstone Capital Management Holdings reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2015 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 2,850 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2015, an estimated $42K.
Cornerstone Capital Management Holdings first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2014 and held it in 4 quarters.
Cornerstone Capital Management Holdings's CTI BioPharma Corp. (DE) Common Stock position peaked at $822K in Q2 2014.
94 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2015, filed 9 Feb 2016.